Safe vincristine use in Switzerland: Still a long way to go?

Brühwiler, Lea D; Schwappach, David (2020). Safe vincristine use in Switzerland: Still a long way to go? Journal of Oncology Pharmacy Practice, 26(1), pp. 51-59. SAGE Publications (UK and US) 10.1177/1078155219835598

[img]
Preview
Text
Brühwiler JOncolPharmPract 2019_epub.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (407kB) | Preview

BACKGROUND Different international organizations recommend safety measures for the use of vincristine to prevent wrong route administrations. A central recommendation is to use infusion bags instead of syringes to prevent confusion with intrathecal chemotherapy. This study aimed to investigate the implementation of safety measures for vincristine and intrathecal chemotherapies in Switzerland. METHOD We conducted a written survey among hospital pharmacies of all general care and pediatric hospitals in Switzerland (n = 102). A responsible person of each hospital pharmacy was invited by email to participate in the online survey in May 2018. RESULTS Of 66 responding hospitals (response rate 65%), 27 have a hospital pharmacy preparing parenteral chemotherapy. All of these hospitals prepared vincristine in 2017, while 21 also prepared intrathecal chemotherapy. Of these 21, 16 hospitals prepared vincristine as syringes, with small volume syringes being the most widely distributed dosage form. A switch from syringes to infusion bags was discussed in seven hospitals, and discussions led to plans for switch in two. The most prevalent safety measures were labeling for vincristine and special delivery for intrathecal drugs. Of hospitals preparing both vincristine syringes and intrathecal chemotherapy, four reported to have no safety measures implemented neither for vincristine nor for intrathecal chemotherapy. CONCLUSION International recommendations are not widely implemented in Swiss hospitals. Syringes are still in use and other safety measures are sparsely disseminated. Thus, Swiss vincristine patients are still at an increased risk for wrong route application. Recommendations have to be further disseminated and implementation could be enhanced.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Schwappach, David

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1078-1552

Publisher:

SAGE Publications (UK and US)

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

21 Mar 2019 09:02

Last Modified:

01 Dec 2019 01:31

Publisher DOI:

10.1177/1078155219835598

PubMed ID:

30866715

Uncontrolled Keywords:

Vincristine medication errors patient safety spinal injections surveys and questionnaires

BORIS DOI:

10.7892/boris.128609

URI:

https://boris.unibe.ch/id/eprint/128609

Actions (login required)

Edit item Edit item
Provide Feedback